Strategic Global Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History

Strategic Global Advisors, LLC

  • $459 Million
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$6.16 - $9.6 $540,305 - $842,035
-87,712 Closed
0 $0
Q2 2019

Aug 13, 2019
SELL
$8.12 - $15.72 $4.35 Million - $8.42 Million
-535,388 Reduced 85.92%
87,712 $810,000
Q1 2019

May 13, 2019
BUY
$15.58 - $20.01 $163,652 - $210,185
10,504 Added 1.71%
623,100 $9.77 Million
Q4 2018

Feb 13, 2019
BUY
$14.59 - $23.84 $3.93 Million - $6.42 Million
269,306 Added 78.45%
612,596 $9.45 Million
Q3 2018

Nov 14, 2018
BUY
$21.06 - $25.65 $7.23 Million - $8.81 Million
343,290 New
343,290 $7.39 Million

Others Institutions Holding TEVA

# of Institutions
543
Shares Held
548M
Call Options Held
19.8M
Put Options Held
14M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Strategic Global Advisors, LLC Portfolio

Follow Strategic Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Global Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email